- Clopidogrel and proton-pump inhibitor interaction viewpoint and.
- Plavix EPAR - Product Information - European Medicines Agency
- Common Side Effects of Plavix Clopidogrel Bisulfate Drug Center.
- Plavix - Sanofi Canada
Clopidogrel and proton-pump inhibitor interaction viewpoint and.
Correspondence: Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, 74 Linjiang Road, Chongqing, China (e-mail: ).
Plavix EPAR - Product Information - European Medicines Agency
Plavix at recommended doses forms less of the active metabolite and so has a reduced effect on platelet activity in patients who are homozygous for nonfunctional alleles of the CYP2C19 gene, (termed "CYP2C19 poor metabolizers").
Common Side Effects of Plavix Clopidogrel Bisulfate Drug Center.
The long-term treatment of patients with coronary artery disease continues to evolve with new therapeutic strategies as well as the development of decision aid tools.
Plavix - Sanofi Canada
The DDI risk does not exhibit a class effect, eg, the effects of clopidogrel on cerivastatin versus other statins, the effects of proton pump inhibitors on clopidogrel (omeprazole, esomeprazole versus pantoprazole, rabeprazole), the effects of rifampicin on clopidogrel versus ticagrelor and prasugrel, and the effects of calcium channel blockers on clopidogrel (amlodipine versus P-glycoprotein-inhibiting calcium channel blockers).
Plavix and clinical implications:
Rating: 88 / 100
Overall: 91 Rates